Marcus Millegård

840 total citations · 1 hit paper
6 papers, 551 citations indexed

About

Marcus Millegård is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Internal Medicine. According to data from OpenAlex, Marcus Millegård has authored 6 papers receiving a total of 551 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Cardiology and Cardiovascular Medicine, 5 papers in Surgery and 2 papers in Internal Medicine. Recurrent topics in Marcus Millegård's work include Antiplatelet Therapy and Cardiovascular Diseases (5 papers), Peripheral Artery Disease Management (4 papers) and Venous Thromboembolism Diagnosis and Management (2 papers). Marcus Millegård is often cited by papers focused on Antiplatelet Therapy and Cardiovascular Diseases (5 papers), Peripheral Artery Disease Management (4 papers) and Venous Thromboembolism Diagnosis and Management (2 papers). Marcus Millegård collaborates with scholars based in Sweden, United Kingdom and Switzerland. Marcus Millegård's co-authors include Lars Norgren, Juuso Blomster, Peter Held, Martin Craig, Jeffrey S. Berger, W. Schuyler Jones, Iris Baumgärtner, Gretchen Heizer, Kenneth W. Mahaffey and Manesh R. Patel and has published in prestigious journals such as New England Journal of Medicine, Circulation and American Heart Journal.

In The Last Decade

Marcus Millegård

6 papers receiving 542 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Ticagrelor versus Clopidogrel in Symptomatic Peripheral Artery Disease

2016 386 citations William R. Hiatt, F. Gerry R. Fowkes et al. New England Journal of Medicine profile →

Peers

Marcus Millegård

SURGE

CCM

PRM

IM

EDM

Daniel Soffer United States

Kiyonori Nanto Japan

Osamu Iida Japan

Yusuke Tomoi Japan

Brian G. Katona United States

M. Behan United Kingdom

Marie-Louise Bartelink Netherlands

Wael Sumaya United Kingdom

T Ammaturo Italy

Mandeep Randhawa United States

Daniel Soffer United States

Marcus Millegård

214 ×0.5

SURGE

439 ×1.1

CCM

85 ×0.5

PRM

105 ×0.6

IM

29 ×0.7

EDM

Citations per year, relative to Marcus Millegård Marcus Millegård (= 1×) peers Daniel Soffer

Countries citing papers authored by Marcus Millegård

Since Specialization

Citations

This map shows the geographic impact of Marcus Millegård's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marcus Millegård with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marcus Millegård more than expected).

Fields of papers citing papers by Marcus Millegård

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marcus Millegård. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marcus Millegård. The network helps show where Marcus Millegård may publish in the future.

Co-authorship network of co-authors of Marcus Millegård

This figure shows the co-authorship network connecting the top 25 collaborators of Marcus Millegård. A scholar is included among the top collaborators of Marcus Millegård based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marcus Millegård. Marcus Millegård is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Ufnal, Marcin, Marcus Millegård, Marco Guazzi, et al.. (2025). Relaxin Mimetic in Pulmonary Hypertension Associated with Left Heart Disease: Design and Rationale of Re-PHIRE. ESC Heart Failure. 12(3). 1956–1964. 1 indexed citations

2.

Berger, Jeffrey S., Beth L. Abramson, Renato D. Lópes, et al.. (2018). Ticagrelor versus clopidogrel in patients with symptomatic peripheral artery disease and prior coronary artery disease: Insights from the EUCLID trial. Vascular Medicine. 23(6). 523–530. 29 indexed citations

3.

Hiatt, William R., F. Gerry R. Fowkes, Gretchen Heizer, et al.. (2016). Ticagrelor versus Clopidogrel in Symptomatic Peripheral Artery Disease. New England Journal of Medicine. 376(1). 32–40. 386 indexed citations breakdown →

4.

Berger, Jeffrey S., Brian G. Katona, W. Schuyler Jones, et al.. (2016). Design and rationale for the Effects of Ticagrelor and Clopidogrel in Patients with Peripheral Artery Disease (EUCLID) trial. American Heart Journal. 175. 86–93. 38 indexed citations

5.

Jones, W. Schuyler, Iris Baumgärtner, William R. Hiatt, et al.. (2016). Ticagrelor Compared With Clopidogrel in Patients With Prior Lower Extremity Revascularization for Peripheral Artery Disease. Circulation. 135(3). 241–250. 96 indexed citations

6.

Bueno, Héctor, Stuart Pocock, Nicolas Danchin, et al.. (2014). Abstract 16705: EPICOR: An International Study of the Duration of Dual Antiplatelet Therapy in Survivors of Acute Coronary Syndromes. 130. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact